New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output
A new report from TEConomy Partners found that the biopharmaceutical industry supports over four million U.S. jobs and over $1.1 trillion in economic output. The biopharmaceutical industry directly employs more than 811,000 people in our country, and each of those jobs supports four additional jobs in other industries. Of the direct industry jobs, 37% are in […]
HINJ Op-Ed: Life Sciences Community Thriving in New Jersey’s ‘2.0 Business Environment’
New Brunswick, NJ, November 13, 2014 ― The Asbury Park Press has published an op-ed by HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean Paranicas regarding New Jersey’s “2.0 business environment” and its impact on the state’s life sciences community. * * * There have been reports that claim that New Jersey […]
HINJ Releases 2013 Economic Impact Report and ‘HINJ and NJ’s Life Sciences Community’ Brochure
New Brunswick, NJ, May 1, 2014 — The HealthCare Institute of New Jersey (HINJ) has released two new publications: the 2013 Economic Impact Report and a new external (leave-behind) brochure entitled HINJ and New Jersey’s Life Sciences Community. Printed copies of each publication are being mailed to HINJ member companies and to our many […]
HINJ to Cosponsor PharmFest 2014; PhRMA CEO John Castellani to Keynote at April 3 Event
New Brunswick, NJ, February 7, 2013 — The HealthCare Institute of New Jersey (HINJ) is pleased to partner, once again, with Montclair State University to sponsor PharmFest, a premier forum that explores emerging issues and trends in the biopharmaceutical and medical technology industry. “PharmFest 2014: The Decade Ahead” will be held on Thursday, April 3 […]
‘NJTV News’ Reports on NJ Life Sciences, HINJ’s 2012 Economic Impact Survey
Montclair, NJ, December 2, 2013 ― It has been called the crown jewel of the New Jersey economy. Citing HINJ’s latest economic impact survey, Lauren Wanko reported on “NJTV News with Mike Schneider” that the biopharmaceutical and medical technology industries generated over $26 billion in economic impact for the Garden State in 2012. “We call […]
HINJ Member Companies’ Economic Impact Exceeds $26 Billion in 2012, Finds New Study Conducted in Association with Deloitte
New Brunswick, NJ, November 13, 2013 ― Key findings from the HealthCare Institute of New Jersey’s (HINJ) 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.” According to the study, which was […]
Choose New Jersey, HINJ and Others Promote NJ as Global Life Science Hub at World’s Largest Biotechnology Event
Chicago, IL, April 23, 2013 — To showcase New Jersey as one of the world’s premiere locations for life science companies and medical research, Choose New Jersey, Inc. is collaborating with Lt. Governor Kim Guadagno, the Business Action Center (BAC), the HealthCare Institute of New Jersey (HINJ), BioNJ and other partners at the BIO International […]